Literature DB >> 15364949

Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.

Ming Zhao1, Antonia Wimmer, Khanh Trieu, Richard G Discipio, Ingrid U Schraufstatter.   

Abstract

Activation of CXCR2 IL-8 receptor leads to activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and rapid receptor endocytosis. Co-immunoprecipitation and co-localization experiments showed that arrestin and CXCR2 form complexes with components of the ERK1/2 cascade following ligand stimulation. However, in contrast to the activation of the beta2-adrenergic receptor, arrestin was not necessary for ERK1/2 phosphorylation or receptor endocytosis. In contrast, beta-arrestin 1/2 double knockout cells showed greatly enhanced phosphorylation of ERK1/2, as well as phosphorylation of the stress kinases p38 and c-Jun N-terminal protein kinase. The stimulation of stress kinases in arrestin double knockout cells could be attenuated in the presence of diphenylene iodonium (DPI), an inhibitor of the NADPH oxidase, suggesting that reactive oxidant species (ROS) participated in mitogen-activated protein kinase (MAPK) activation. ROS could indeed be detected in IL-8-stimulated beta-arrestin 1/2 knockout cells, and cytoplasmic Rac was translocated to the membrane fraction, which is a prerequisite for oxidant formation. The oxidative burst induced cell death within 6 h of IL-8 stimulation of these cells, which could be prevented in the presence of DPI. These results indicate a novel function for arrestin, which is protection from an excessive oxidative burst, resulting from the sustained stimulation of G-protein-coupled receptors that cause Rac translocation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364949     DOI: 10.1074/jbc.M405118200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

2.  CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.

Authors:  Gong Yang; Daniel G Rosen; Guangzhi Liu; Fan Yang; Xiaoqing Guo; Xue Xiao; Fengxia Xue; Imelda Mercado-Uribe; Jiaoti Huang; Sue-Hwa Lin; Gordon B Mills; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-05-26       Impact factor: 12.531

3.  Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.

Authors:  Mohd W Nasser; Sandeep K Raghuwanshi; Delores J Grant; Venkatakrishna R Jala; Krishna Rajarathnam; Ricardo M Richardson
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

4.  Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor.

Authors:  Jennifer L Halpern; Amy Kilbarger; Conor C Lynch
Journal:  Cancer Lett       Date:  2011-05-23       Impact factor: 8.679

Review 5.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

Review 6.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

7.  A novel phenylcyclohex-1-enecarbothioamide derivative inhibits CXCL8-mediated chemotaxis through selective regulation of CXCR2-mediated signalling.

Authors:  Helen Ha; Tim Bensman; Henry Ho; Paul M Beringer; Nouri Neamati
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma.

Authors:  Ping Sui; Pingping Hu; Tiehong Zhang; Xiangwei Zhang; Qi Liu; Jiajun Du
Journal:  Med Oncol       Date:  2013-12-17       Impact factor: 3.064

9.  Deletion of β-Arrestin2 in Mice Limited Pancreatic β-Cell Expansion under Metabolic Stress through Activation of the JNK Pathway.

Authors:  Ziwei Lin; Yu Zhao; Lige Song; Kaida Mu; Mingliang Zhang; Hongxia Liu; Xiaowen Li; Jian Zhao; Chen Wang; Weiping Jia
Journal:  Mol Med       Date:  2016-02-29       Impact factor: 6.354

10.  A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors.

Authors:  Kaizheng Gong; Zijian Li; Ming Xu; Jianhai Du; Zhizhen Lv; Youyi Zhang
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.